VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $626,679 | -30.6% | 23,288 | -16.6% | 0.00% | -20.0% |
Q2 2023 | $903,631 | 0.0% | 27,933 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $903,631 | -0.2% | 27,933 | -11.6% | 0.01% | 0.0% |
Q4 2022 | $905,168 | -4.2% | 31,583 | -19.5% | 0.01% | -16.7% |
Q3 2022 | $945,000 | -12.4% | 39,239 | -0.5% | 0.01% | 0.0% |
Q2 2022 | $1,079,000 | -53.7% | 39,449 | -35.1% | 0.01% | -45.5% |
Q1 2022 | $2,332,000 | +21.2% | 60,830 | +1.2% | 0.01% | +22.2% |
Q4 2021 | $1,924,000 | +74.4% | 60,101 | +60.3% | 0.01% | +50.0% |
Q3 2021 | $1,103,000 | -21.4% | 37,491 | -9.3% | 0.01% | -14.3% |
Q2 2021 | $1,403,000 | +4.5% | 41,325 | +0.0% | 0.01% | 0.0% |
Q1 2021 | $1,342,000 | -31.4% | 41,312 | -24.0% | 0.01% | -36.4% |
Q4 2020 | $1,957,000 | -13.8% | 54,358 | -6.3% | 0.01% | -21.4% |
Q3 2020 | $2,270,000 | +90.8% | 58,013 | +78.6% | 0.01% | +100.0% |
Q2 2020 | $1,190,000 | +16.7% | 32,491 | -6.8% | 0.01% | +40.0% |
Q1 2020 | $1,020,000 | 0.0% | 34,851 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $1,020,000 | +6.5% | 34,851 | -2.9% | 0.01% | +25.0% |
Q3 2019 | $958,000 | +3.3% | 35,881 | -1.1% | 0.00% | 0.0% |
Q2 2019 | $927,000 | -0.2% | 36,281 | -12.5% | 0.00% | 0.0% |
Q1 2019 | $929,000 | +18.6% | 41,481 | +11.7% | 0.00% | 0.0% |
Q4 2018 | $783,000 | -7.7% | 37,150 | -19.0% | 0.00% | +33.3% |
Q3 2018 | $848,000 | -16.5% | 45,852 | +0.7% | 0.00% | -25.0% |
Q2 2018 | $1,016,000 | 0.0% | 45,529 | +4.0% | 0.00% | 0.0% |
Q1 2018 | $1,016,000 | 0.0% | 43,790 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,016,000 | -10.0% | 43,790 | -11.1% | 0.00% | -20.0% |
Q3 2017 | $1,129,000 | +40.2% | 49,236 | +39.4% | 0.01% | +25.0% |
Q2 2017 | $805,000 | 0.0% | 35,330 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $805,000 | +11.5% | 35,330 | +2.2% | 0.00% | 0.0% |
Q4 2016 | $722,000 | -42.7% | 34,579 | -27.5% | 0.00% | -42.9% |
Q3 2016 | $1,259,000 | +9.3% | 47,684 | +14.6% | 0.01% | 0.0% |
Q2 2016 | $1,152,000 | – | 41,619 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |